Hospital executives are forecasting significant coverage losses and financial strain from federal Medicaid policy changes including work requirements, more frequent eligibility checks, and limits on state financing mechanisms. Community Health Systems reports that Medicaid volume already declined 7-10% during recent redeterminations in some states, and leaders expect further erosion in payer mix and increased uncompensated care concentrated in emergency departments. The discussion emphasizes that MCOs and providers need granular, real-time analytics by state and service line to model local impact rather than relying on national estimates.

HHS has appointed eight new members to the U.S. Preventive Services Task Force after more than a year of inactivity, restoring the panel to 16 members with a notably different composition that includes more specialists and fewer primary care physicians. The reconstitution matters for Medicaid managed care because USPSTF recommendations with A or B grades trigger mandatory coverage without cost-sharing under the ACA, affecting benefit design, utilization management, and preventive service demand across health plans. The panel's new makeup and potential shifts in evidence review approaches could influence future preventive care coverage requirements.

CMS has proposed implementing the OBBBA's provider tax changes with significant new details: state-specific thresholds based on taxes in place as of July 2025, a zero-percent threshold for new tax classes, exemptions for non-expansion states and certain facility types, and elimination of the 75/75 workaround pathway. The rule would reduce federal Medicaid spending by $246 billion over ten years—substantially more than originally estimated—forcing states and MCOs to fundamentally rethink Medicaid financing strategies. The proposal also introduces health insurers as a newly permissible tax class, directly affecting managed care plan operations and rate structures.

Sellers Dorsey argues that healthcare providers—including Medicaid managed care plans—should move beyond one-time referrals to kinship navigator programs and establish ongoing, two-way coordination with child welfare systems. The piece explains that kinship caregivers (relatives raising children during family crises) face complex needs around coverage verification, behavioral health access, and legal guardianship that require continuous collaboration, not just handoffs. For MCOs, this means building formal partnerships with navigator programs to improve care coordination, address social determinants, and stabilize placements for vulnerable Medicaid-enrolled children.

Health systems face pressure to redesign primary care delivery around patient segmentation based on clinical risk, social determinants, and care preferences rather than one-size-fits-all models. The piece argues that differentiated care pathways can improve access, reduce provider burnout, and position primary care as a growth engine while managing increasingly complex patient populations. For Medicaid MCOs managing high-need populations with significant social complexity, these segmentation approaches may inform care coordination and network adequacy strategies.

Analysis of Q2 2026 earnings from six major publicly traded health plans shows Medicaid managed care operations are under financial strain due to higher-than-expected member acuity and uncertainty around state payment rates and policy changes including redeterminations and work requirements. Unlike Medicare Advantage where plans are prioritizing profitability over growth, Medicaid MCOs remain heavily dependent on state rate adequacy amid ongoing eligibility policy shifts. The findings highlight continuing challenges for Medicaid plan financial sustainability as post-pandemic enrollment dynamics stabilize.

States must simultaneously implement overlapping work requirement changes in both Medicaid and SNAP affecting many of the same beneficiaries, with roughly one in five adults subject to new Medicaid work rules also receiving nutrition assistance. The federal law creates direct program linkages—SNAP participation automatically satisfies Medicaid work requirements, and medical frailty determinations now align across both programs—requiring unprecedented coordination between historically separate state agencies. Both programs carry significant financial penalties for eligibility errors, with Medicaid facing reduced federal funding for payment error rates above 3% starting in FY 2026.

Sellers Dorsey outlines approaches for state Medicaid programs to balance community integration commitments with fiscal pressures in home and community-based services. The piece addresses operational challenges including 607,000 people on HCBS waiting lists, workforce shortages, and cost growth outpacing enrollment, while noting evolving federal expectations for transparency and program integrity. The analysis is framed around maintaining ADA compliance while managing waiver capacity constraints and rising per-member costs.

This white paper argues that while fraud enforcement in healthcare has reached record levels, waste and abuse represent larger sources of overspending that require different strategies than traditional program integrity approaches. The authors distinguish between fraud, waste, and abuse as separate problems requiring tailored solutions, and propose five evidence-based approaches for Medicaid and Medicare payers to address waste and abuse through collaboration with providers rather than purely adversarial enforcement. The analysis is particularly relevant for MCO compliance teams balancing program integrity requirements with provider network relationships.

Avalere's new explainer video series addresses regulatory changes affecting health plans, with episodes covering Medicare Advantage risk adjustment methodology shifts, the Clover Health Stars lawsuit implications, and heightened federal program integrity enforcement. While focused primarily on Medicare Advantage rather than Medicaid managed care, the compliance and regulatory themes—particularly around fraud, waste, and abuse oversight—have parallel implications for Medicaid MCO operations and state oversight strategies.

The SUSTAIN 340B legislation codifies point-of-sale discounts for covered entities including Medicaid safety-net providers, requires manufacturers to honor 340B pricing regardless of contract pharmacy arrangements, and introduces new program integrity standards including clearinghouse oversight for duplicate discount prevention. For Medicaid MCOs and state agencies, the bill would formalize contract pharmacy protections while adding transparency requirements that could affect claims processing, pharmacy network management, and coordination between 340B discounts and Medicaid rebates. The proposal would also sunset CMS's planned rebate model pilot within a year of enactment.

CMS's proposed standardized refund methodologies under the Medicare Drug Negotiation Program would calculate manufacturer rebates differently depending on whether drugs have deep existing discounts or not, creating varying financial impacts across competitive drug classes. This matters for Medicaid managed care because the Medicare negotiated prices will serve as benchmarks and could reshape manufacturer pricing strategies and discount structures that MCOs rely on for pharmacy benefits. Plans with formularies weighted toward either high-discount or low-discount competitive classes may face different financial exposure as these Medicare pricing policies take effect.

CMS's Center for Program Integrity is dramatically scaling up its fraud prevention efforts using AI-powered claims screening and a centralized fraud operations center, achieving a 22:1 return on investment in 2025. The agency is shifting from a pay-and-chase model to pre-payment intervention, using real-time risk scoring to flag suspicious claims before funds are released. While the article focuses on Medicare fee-for-service examples, the fraud detection infrastructure and analytic capabilities discussed apply across CMS programs including Medicaid managed care, where program integrity is a core compliance responsibility for MCOs and state oversight agencies.

State prescription drug affordability boards are increasingly tying their price caps to Medicare negotiated prices rather than developing independent methodologies, with Colorado and Maryland leading this approach for products like Enbrel and Ozempic. However, no upper payment limit has actually taken effect yet, some states have dissolved their boards entirely, and aggressive bills in Virginia have faced repeated vetoes. The shift matters for Medicaid MCOs because these state pricing controls would directly affect pharmacy reimbursement rates and formulary strategies if they ultimately go into effect.

This quarterly tracker reviews the expanding landscape of AI regulation affecting health care, noting that 20 states enacted AI legislation in the first half of 2026 with particular attention to health plan and provider AI use, patient-facing chatbots, and transparency mandates. The piece highlights several federal developments including proposed changes to CMS payment for AI-enabled software services and potential liability frameworks, which could directly affect how Medicaid MCOs deploy predictive analytics, utilization management tools, and member-facing technologies. While the analysis covers the broader health sector, Medicaid payers are explicitly mentioned as stakeholders who should prepare for compliance with emerging AI disclosure and safety requirements.

Sellers Dorsey explores how schools can function as coordination hubs connecting Medicaid-funded behavioral health services with child welfare agencies and community providers. The brief addresses fragmentation across systems serving children and proposes schools as an access point for integrating care delivery. This model has direct implications for MCO network adequacy, care coordination strategies, and how managed care plans structure pediatric behavioral health benefits and community partnerships.

CMS has proposed replacing the current 6% indirect hold harmless threshold for health care-related taxes with state-specific thresholds, implementing provisions from federal budget reconciliation legislation. The rule would phase down thresholds for expansion states starting in 2028, add health insurers as a new permissible tax class, eliminate the 75/75 test, and create new reporting requirements. With an estimated $246 billion reduction in federal Medicaid spending over ten years, this proposal has significant implications for how states finance their Medicaid programs and could affect MCO premium rates and overall program funding.

The $50 billion Rural Health Transformation Program is enabling states to scale school-based health care in rural areas, with particular emphasis on behavioral health access. While school-based health isn't new, RHTP's flexibility allows states to fund workforce, telehealth infrastructure, and sustainable care delivery models that could create new partnership and network adequacy opportunities for Medicaid managed care organizations serving rural populations. The analysis suggests successful models will require partnerships between schools and health care organizations with clinical and administrative capacity—roles MCOs may be positioned to fill.

With H.R. 1's work requirements expected to cause 5.3 million people to lose Medicaid expansion coverage by 2034, state family planning programs will become a critical safety net as federal rules require eligibility screening for all other coverage pathways before termination. States should strengthen their family planning programs now by investing in provider networks, benefits, systems, and outreach to handle the influx while preserving access to contraceptive care in a post-Dobbs environment. These efforts align with broader maternal health initiatives like 12-month postpartum coverage extensions.

A Manatt-supported convening examined how payment structures need to evolve as clinical AI moves from assistive to autonomous roles in care delivery, with participants concluding that existing fee-for-service models will inflate costs while value-based arrangements remain insufficient without redesign. The discussion highlighted that AI's ability to substitute technology for clinical labor requires fundamentally new, outcome-based payment approaches rather than incremental modifications. For Medicaid MCOs navigating capitated arrangements and quality incentives, these emerging payment frameworks could significantly affect how AI-enabled services are contracted and how savings from automation are captured or shared.